Format

Send to:

Choose Destination
See comment in PubMed Commons below
Clin Breast Cancer. 2003 Aug;4(3):212-7.

Phase I/II study of treatment of stage IV breast cancer with OKT3 x trastuzumab-armed activated T cells.

Author information

  • 1Immunotherapy and Blood and Stem Cell Transplantation Programs, Adele R. Decof Cancer Center, Roger Williams Medical Center, Providence, RI 02908, USA. llum@rwmc.org
PMID:
14499016
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk